Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's Intraday Session

Author: Benzinga Insights | October 12, 2023 01:37pm

Gainers

  • OpGen (NASDAQ:OPGN) shares increased by 429.8% to $1.78 during Thursday's regular session. OpGen's stock is trading at a volume of 53.1 million shares as of 13:37 EST. This is 2370.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $15.8 million.
  • Atreca (NASDAQ:BCEL) stock increased by 58.26% to $0.37. Trading volume for Atreca's stock is 57.0 million as of 13:37 EST. This is 23534.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $14.6 million.
  • Jaguar Health (NASDAQ:JAGX) shares moved upwards by 44.5% to $0.35. As of 13:37 EST, Jaguar Health's stock is trading at a volume of 109.9 million, which is 13194.7% of its average full-day volume over the last 100 days. The company's market cap stands at $6.6 million.
  • LogicMark (NASDAQ:LGMK) stock moved upwards by 35.48% to $2.1. Trading volume for LogicMark's stock is 700.9K as of 13:37 EST. This is 985.6% of its average full-day volume over the last 100 days. The company's market cap stands at $2.7 million.
  • Processa Pharma (NASDAQ:PCSA) shares increased by 31.57% to $0.3. Trading volume for this security as of 13:37 EST is 704.4K, which is 658.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $7.3 million.
  • Reshape Lifesciences (NASDAQ:RSLS) stock moved upwards by 29.25% to $0.35. As of 13:37 EST, Reshape Lifesciences's stock is trading at a volume of 67.8 million, which is 16163.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.8 million.

Losers

  • RVL Pharmaceuticals (NASDAQ:RVLP) stock declined by 62.8% to $0.06 during Thursday's regular session. As of 13:37 EST, this security is trading at a volume of 76.8 million shares, making up 517.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.5 million.
  • Tempest Therapeutics (NASDAQ:TPST) shares declined by 57.92% to $4.11. Tempest Therapeutics's stock is trading at a volume of 37.7 million shares as of 13:37 EST. This is 1183.1% of its average full-day volume over the last 100 days. The company's market cap stands at $54.7 million.
  • T2 Biosystems (NASDAQ:TTOO) stock fell 43.96% to $0.17. The current volume of 142.5 million shares is 129.1% of T2 Biosystems's average full-day volume over the last 100 days (last updated at 13:37 EST). The company's market cap stands at $57.9 million.
  • Agape ATP (NASDAQ:ATPC) stock decreased by 39.02% to $1.11. Trading volume for Agape ATP's stock is 665.1K as of 13:37 EST. This is 29.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $83.7 million.
  • Phio Pharma (NASDAQ:PHIO) shares fell 38.85% to $1.59. As of 13:37 EST, Phio Pharma's stock is trading at a volume of 2.1 million, which is 240.7% of its average full-day volume over the last 100 days. The company's market cap stands at $3.5 million.
  • PMV Pharma (NASDAQ:PMVP) shares decreased by 33.69% to $3.15. As of 13:37 EST, PMV Pharma's stock is trading at a volume of 1.1 million, which is 277.9% of its average full-day volume over the last 100 days. The company's market cap stands at $152.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ATPC BCEL JAGX LGMK OPGN PCSA PHIO PMVP RSLS RVLP TPST TTOO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist